These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33010393)

  • 1. Environmental toxins and Alzheimer's disease progression.
    Vasefi M; Ghaboolian-Zare E; Abedelwahab H; Osu A
    Neurochem Int; 2020 Dec; 141():104852. PubMed ID: 33010393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.
    Rao RV; Subramaniam KG; Gregory J; Bredesen AL; Coward C; Okada S; Kelly L; Bredesen DE
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of environmental pollutants in Alzheimer's disease: a review.
    Mir RH; Sawhney G; Pottoo FH; Mohi-Ud-Din R; Madishetti S; Jachak SM; Ahmed Z; Masoodi MH
    Environ Sci Pollut Res Int; 2020 Dec; 27(36):44724-44742. PubMed ID: 32715424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metals in the etiology of Alzheimer's disease.
    Shcherbatykh I; Carpenter DO
    J Alzheimers Dis; 2007 May; 11(2):191-205. PubMed ID: 17522444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?
    Chin-Chan M; Cobos-Puc L; Alvarado-Cruz I; Bayar M; Ermolaeva M
    J Biol Inorg Chem; 2019 Dec; 24(8):1285-1303. PubMed ID: 31773268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.
    Wong BX; Hung YH; Bush AI; Duce JA
    Front Aging Neurosci; 2014; 6():91. PubMed ID: 24860500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Zaman S; Begum Y; Ashraf GM; Bin-Jumah MN; Bungau SG; Mousa SA; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):1-20. PubMed ID: 32889653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation.
    Dhapola R; Sharma P; Kumari S; Bhatti JS; HariKrishnaReddy D
    Mol Neurobiol; 2024 Jun; 61(6):3657-3677. PubMed ID: 38006469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Environmental pollutants and Alzheimer's disease].
    Guo B; Ba Q
    Sheng Li Xue Bao; 2023 Dec; 75(6):740-766. PubMed ID: 38151341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oxidative stress in the progression of Alzheimer's disease.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2010; 19(1):341-53. PubMed ID: 20061649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.
    Huat TJ; Camats-Perna J; Newcombe EA; Valmas N; Kitazawa M; Medeiros R
    J Mol Biol; 2019 Apr; 431(9):1843-1868. PubMed ID: 30664867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.